| Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis R Rajasingham, RM Smith, BJ Park, JN Jarvis, NP Govender, TM Chiller, ... The Lancet infectious diseases 17 (8), 873-881, 2017 | 1857 | 2017 |
| A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19 DR Boulware, MF Pullen, AS Bangdiwala, KA Pastick, SM Lofgren, ... New England journal of medicine 383 (6), 517-525, 2020 | 1556 | 2020 |
| Hydroxychloroquine in nonhospitalized adults with early COVID-19: a randomized trial CP Skipper, KA Pastick, NW Engen, AS Bangdiwala, M Abassi, ... Annals of internal medicine 173 (8), 623-631, 2020 | 639 | 2020 |
| Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis DR Boulware, DB Meya, C Muzoora, MA Rolfes, K Huppler Hullsiek, ... New England Journal of Medicine 370 (26), 2487-2498, 2014 | 500 | 2014 |
| Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death DR Boulware, KH Hullsiek, CE Puronen, A Rupert, JV Baker, MA French, ... Journal of Infectious Diseases 203 (11), 1637-1646, 2011 | 361 | 2011 |
| Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy A Kambugu, DB Meya, J Rhein, M O'Brien, EN Janoff, AR Ronald, ... Clinical infectious diseases 46 (11), 1694-1701, 2008 | 361 | 2008 |
| Cost-Effectiveness of Serum Cryptococcal Antigen Screening to Prevent Deaths among HIV-Infected Persons with a CD4+ Cell Count ≤100 Cells/μL Who Start … DB Meya, YC Manabe, B Castelnuovo, BA Cook, AM Elbireer, ... Clinical infectious diseases 51 (4), 448-455, 2010 | 340 | 2010 |
| Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions LJ Haddow, R Colebunders, G Meintjes, SD Lawn, JH Elliott, YC Manabe, ... The Lancet infectious diseases 10 (11), 791-802, 2010 | 333 | 2010 |
| Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast DR Boulware, MA Rolfes, R Rajasingham, M von Hohenberg, Z Qin, ... Emerging infectious diseases 20 (1), 45, 2014 | 325 | 2014 |
| Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study DR Boulware, DB Meya, TL Bergemann, DL Wiesner, J Rhein, ... PLoS medicine 7 (12), e1000384, 2010 | 325 | 2010 |
| Travel medicine considerations for North American immigrants visiting friends and relatives N Bacaner, B Stauffer, DR Boulware, PF Walker, JS Keystone Jama 291 (23), 2856-2864, 2004 | 312 | 2004 |
| Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study NC Bahr, E Nuwagira, EE Evans, FV Cresswell, PV Bystrom, ... The Lancet infectious diseases 18 (1), 68-75, 2018 | 308 | 2018 |
| Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19) KA Pastick, EC Okafor, F Wang, SM Lofgren, CP Skipper, MR Nicol, ... Open forum infectious diseases 7 (4), ofaa130, 2020 | 235 | 2020 |
| Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome DR Boulware, SC Bonham, DB Meya, DL Wiesner, GS Park, A Kambugu, ... Journal of Infectious Diseases 202 (6), 962, 2010 | 227 | 2010 |
| Significantly improved analytical sensitivity of lateral flow immunoassays by using thermal contrast Z Qin, WCW Chan, DR Boulware, T Akkin, EK Butler, JC Bischof Angewandte Chemie International Edition 51 (18), 4358-4361, 2012 | 217 | 2012 |
| Effect of early treatment with ivermectin among patients with Covid-19 G Reis, EASM Silva, DCM Silva, L Thabane, AC Milagres, TS Ferreira, ... New England Journal of Medicine 386 (18), 1721-1731, 2022 | 196 | 2022 |
| Increased antifungal drug resistance in clinical isolates of Cryptococcus neoformans in Uganda KD Smith, B Achan, KH Hullsiek, TR McDonald, LH Okagaki, AA Alhadab, ... Antimicrobial agents and chemotherapy 59 (12), 7197-7204, 2015 | 193 | 2015 |
| The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis R Rajasingham, NP Govender, A Jordan, A Loyse, A Shroufi, ... The Lancet infectious diseases 22 (12), 1748-1755, 2022 | 191 | 2022 |
| Chitin recognition via chitotriosidase promotes pathologic type-2 helper T cell responses to cryptococcal infection DL Wiesner, CA Specht, CK Lee, KD Smith, L Mukaremera, ST Lee, ... PLoS pathogens 11 (3), e1004701, 2015 | 186 | 2015 |
| Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19 CT Bramante, JD Huling, CJ Tignanelli, JB Buse, DM Liebovitz, ... New England Journal of Medicine 387 (7), 599-610, 2022 | 185 | 2022 |
David MeyaAssociate Professor, College of Health Sciences, Makerere University; Adjunct Associate ProfessorVerifierad e-postadress på mak.ac.ug
